Safety and efficacy of non–vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation

BACKGROUND: In trials of patients with atrial fibrillation (AF), non–vitamin K antagonist oral anticoagulants (NOACs) were not inferior to warfarin for thromboembolic and bleeding events. However, there are scant data comparing the efficacy and safety of NOACs in patients with AF with that of well-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamkasikorn, Janekij, Methavigul, Komsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Brief Communication (Original)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321168/
https://www.ncbi.nlm.nih.gov/pubmed/37551377
http://dx.doi.org/10.2478/abm-2022-0016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321168/
https://www.ncbi.nlm.nih.gov/pubmed/37551377
http://dx.doi.org/10.2478/abm-2022-0016

Ejemplares similares